Skip to content

Different Treatments With the TRV Reposition Chair

Which Repositional Maneuver is the Most Successful When Treating Lateral and Posterior Benign Paroxysmal Positional Vertigo With the TRV Repositional Chair?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03541018
Enrollment
100
Registered
2018-05-30
Start date
2018-01-01
Completion date
2022-01-01
Last updated
2022-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Paroxysmal Positional Vertigo

Keywords

TRV Reposition Chair, Epley Maneuvre

Brief summary

To investigate which treatment option (reposition maneuver) with the TRV chair that is the most effective in patients diagnosed with benign paroxysmal positional vertigo (BPPV). Subtypes of BPPV will be examined after randomization to specific treatments.

Detailed description

Patients diagnosed with BPPV with subtypes of either posterior canalolithiasis or lateral cupulolithiasis will we considered for enrollment. Each subgroup of patients will undergo randomization for a specific treatment.

Interventions

PROCEDUREType of repositional maneuvre

Patients randomized to 2 different repositional maneuvres related to the subtypes of BPPV

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age above 18 years of age * Medical history compatible with BPPV * Verification of BPPV with either Dix-Hallpike Maneuver or Supine Roll Test.

Exclusion criteria

* Former treatment with a repositional Chair * Not being able to participate or cooperate in the treatment provided by the TRV Repositional Chair

Design outcomes

Primary

MeasureTime frameDescription
Evaluation by VNG Measurements2 yearsVideo NystagmoGraphy (VNG) equipment will objectively quantify nystagmus characteristics during diagnostic procedures.
Subjective vertigo2 yearsA systematic registration of experienced vertigo during each diagnostic procedure will take place.

Secondary

MeasureTime frameDescription
Dizziness Handicap Inventory (DHI) questionnaire2 yearsPre-treatment fulfillment of the questionnaire Dizziness Handicap Inventory (DHI) will quantify the level of experienced vertigo.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026